Form 8-K - Current report:
SEC Accession No. 0000950170-21-005196
Filing Date
2021-12-14
Accepted
2021-12-14 16:05:29
Documents
12
Period of Report
2021-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20211210.htm   iXBRL 8-K 47659
  Complete submission text file 0000950170-21-005196.txt   162045

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20211210_pre.xml EX-101.PRE 9589
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20211210_lab.xml EX-101.LAB 12936
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20211210.xsd EX-101.SCH 2501
5 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20211210_htm.xml XML 4540
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 211491031
SIC: 2834 Pharmaceutical Preparations